+

WO1995035275B1 - Inhibiteurs de metalloproteinases - Google Patents

Inhibiteurs de metalloproteinases

Info

Publication number
WO1995035275B1
WO1995035275B1 PCT/GB1995/001464 GB9501464W WO9535275B1 WO 1995035275 B1 WO1995035275 B1 WO 1995035275B1 GB 9501464 W GB9501464 W GB 9501464W WO 9535275 B1 WO9535275 B1 WO 9535275B1
Authority
WO
WIPO (PCT)
Prior art keywords
alk
group
alkyl
hydrogen
sulphonyl
Prior art date
Application number
PCT/GB1995/001464
Other languages
English (en)
Other versions
WO1995035275A1 (fr
Filing date
Publication date
Priority claimed from GB9412514A external-priority patent/GB9412514D0/en
Priority claimed from GBGB9506107.3A external-priority patent/GB9506107D0/en
Priority to DE69516143T priority Critical patent/DE69516143T2/de
Priority to AT95922638T priority patent/ATE191468T1/de
Priority to AU27465/95A priority patent/AU695507B2/en
Priority to DK95922638T priority patent/DK0766664T3/da
Priority to GB9623809A priority patent/GB2303629B/en
Priority to JP8501847A priority patent/JPH10501806A/ja
Application filed filed Critical
Priority to US08/765,140 priority patent/US5962529A/en
Priority to NZ288298A priority patent/NZ288298A/xx
Priority to EP95922638A priority patent/EP0766664B1/fr
Publication of WO1995035275A1 publication Critical patent/WO1995035275A1/fr
Publication of WO1995035275B1 publication Critical patent/WO1995035275B1/fr
Priority to KR1019960707283A priority patent/KR970703937A/ko
Priority to NO965515A priority patent/NO965515L/no
Priority to GR20000401133T priority patent/GR3033446T3/el

Links

Abstract

L'invention se rapporte à des composés de la formule (II) dans laquelle X représente un groupe d'acide hydroxamique ou carboxylique, Y représente carbonyle ou sulfonyle et R1 et R2 sont tels que définis dans les revendications et sont des inhibiteurs de métalloprotéinases matricielles.
PCT/GB1995/001464 1994-06-22 1995-06-22 Inhibiteurs de metalloproteinases WO1995035275A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
NZ288298A NZ288298A (en) 1994-06-22 1995-06-22 Hydroxamic acid and carboxylic acid derivatives; medicaments containing such derivatives that are metalloproteinase inhibitors
EP95922638A EP0766664B1 (fr) 1994-06-22 1995-06-22 Inhibiteurs de metalloproteinases
US08/765,140 US5962529A (en) 1994-06-22 1995-06-22 Metalloproteinase inhibitors
AU27465/95A AU695507B2 (en) 1994-06-22 1995-06-22 Metalloproteinase inhibitors
DK95922638T DK0766664T3 (da) 1994-06-22 1995-06-22 Metalloproteinaseinhibitorer
GB9623809A GB2303629B (en) 1994-06-22 1995-06-22 Hydroxamic acids and their use as metalloproteinase inhibitors
JP8501847A JPH10501806A (ja) 1994-06-22 1995-06-22 金属タンパク質分解酵素阻害剤
DE69516143T DE69516143T2 (de) 1994-06-22 1995-06-22 Metalloproteinase inhibitoren
AT95922638T ATE191468T1 (de) 1994-06-22 1995-06-22 Metalloproteinase inhibitoren
KR1019960707283A KR970703937A (ko) 1995-03-24 1996-12-19 금속단백질 분해효소 억제제(Metallproteinase inhibitors)
NO965515A NO965515L (no) 1994-06-22 1996-12-20 Metalloproteinaseinhibitorer
GR20000401133T GR3033446T3 (en) 1994-06-22 2000-05-18 Metalloproteinase inhibitors

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9412514A GB9412514D0 (en) 1994-06-22 1994-06-22 Metalloproteinase inhibitors
GB9412514.3 1994-06-22
GBGB9506107.3A GB9506107D0 (en) 1995-03-24 1995-03-24 Metalloproteinase inhibitors
GB9506107.3 1995-03-24

Publications (2)

Publication Number Publication Date
WO1995035275A1 WO1995035275A1 (fr) 1995-12-28
WO1995035275B1 true WO1995035275B1 (fr) 1996-01-18

Family

ID=26305102

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB1995/001465 WO1995035276A1 (fr) 1994-06-22 1995-06-22 Inhibiteurs de metalloproteinases
PCT/GB1995/001464 WO1995035275A1 (fr) 1994-06-22 1995-06-22 Inhibiteurs de metalloproteinases

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/001465 WO1995035276A1 (fr) 1994-06-22 1995-06-22 Inhibiteurs de metalloproteinases

Country Status (17)

Country Link
US (4) US5962529A (fr)
EP (2) EP0766664B1 (fr)
JP (2) JPH10501806A (fr)
CN (1) CN1151157A (fr)
AT (2) ATE191468T1 (fr)
AU (2) AU690703B2 (fr)
CA (2) CA2193692A1 (fr)
DE (2) DE69511089T2 (fr)
DK (2) DK0766664T3 (fr)
ES (2) ES2145913T3 (fr)
FI (1) FI965153A0 (fr)
GB (2) GB2303629B (fr)
GR (2) GR3031143T3 (fr)
NO (1) NO965515L (fr)
NZ (2) NZ288299A (fr)
PT (1) PT766664E (fr)
WO (2) WO1995035276A1 (fr)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646167A (en) * 1993-01-06 1997-07-08 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamix acids
US6380366B1 (en) * 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
JPH10501806A (ja) * 1994-06-22 1998-02-17 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
US5817822A (en) * 1994-06-24 1998-10-06 Novartis Corporation Certain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acids
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
KR980009238A (ko) 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
ES2185750T3 (es) * 1995-08-08 2003-05-01 Ono Pharmaceutical Co Derivados de acido hidroxamico utiles para la inhibicion gelatinasa.
PL186869B1 (pl) † 1995-11-13 2004-03-31 Hoechst Ag Nowe heterocykliczne N-podstawione pochodne kwasów alfa-iminohydroksamowych i karboksylowych, sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie
IL124559A (en) * 1995-12-08 2004-07-25 Agouron Pharma Inhibitors of metalloproteinases, pharmaceutical preparations containing them and their use
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
TW453995B (en) * 1995-12-15 2001-09-11 Novartis Ag Certain alpha-substituted arylsulfonamido acetohydroxamic acids
TR199801419T2 (xx) * 1996-01-23 1998-10-21 Shionogi & Co.Ltd. S�lfone amino asit t�revleri ve ayn� i�erikte metaloproteinez �nleyicileri.
CA2242416C (fr) * 1996-01-23 2006-03-21 Shionogi & Co., Ltd. Derives d'acides amines sulfones et inhibiteurs de metalloproteinases contenant ces derives
US6919375B1 (en) 1996-01-23 2005-07-19 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
US5994351A (en) * 1998-07-27 1999-11-30 Pfizer Inc. Arylsulfonylamino hydroxamic acid derivatives
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL126832A0 (en) * 1996-05-17 1999-08-17 Warner Lambert Co Biphenylsulfonamide matrix metalloproteinase inhibitors
JP2000516607A (ja) * 1996-08-16 2000-12-12 ワーナー―ランバート・コンパニー 酪酸マトリックスメタロプロテイナーゼ阻害剤
SK21499A3 (en) * 1996-08-23 2000-05-16 Pfizer Arylsulfonylamino hydroxamic acid derivatives
BR9713186A (pt) * 1996-08-28 1999-11-03 Procter & Gamble Inibidores de metaloprotease 1,3-diheterocìclicos
EP0927183B1 (fr) * 1996-08-28 2004-07-28 THE PROCTER & GAMBLE COMPANY Inhibiteurs de metalloproteases spirocycliques
ATE231132T1 (de) * 1996-08-28 2003-02-15 Procter & Gamble Heterocyclische metalloprotease inhibitoren
BR9712792A (pt) * 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.
SK25499A3 (en) * 1996-08-28 2000-03-13 Procter & Gamble Phosphinic acid amides as matrix metalloprotease inhibitors
TR199900382T2 (xx) * 1996-08-28 1999-05-21 The Procter & Gamble Company Heterosiklik metaloproteaz inhibit�rleri.
US5929097A (en) * 1996-10-16 1999-07-27 American Cyanamid Company Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
US6548524B2 (en) 1996-10-16 2003-04-15 American Cyanamid Company Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
US5962481A (en) * 1996-10-16 1999-10-05 American Cyanamid Company Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
US6228869B1 (en) 1996-10-16 2001-05-08 American Cyanamid Company Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
ES2166102T3 (es) * 1996-10-16 2002-04-01 American Cyanamid Co Preparacion y utilizacion de acidos orto-sulfonamidoarilhidroxamicos como inhibidores de las metaloproteinasas matriz y los tace.
US5977408A (en) * 1996-10-16 1999-11-02 American Cyanamid Company Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
JP2001503400A (ja) * 1996-10-22 2001-03-13 ファルマシア・アンド・アップジョン・カンパニー マトリックス・メタロプロテイナーゼ阻害剤としてのα―アミノスルホニルヒドロキサム酸類
US6008243A (en) * 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
US6174915B1 (en) 1997-03-25 2001-01-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6281245B1 (en) 1996-10-28 2001-08-28 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
WO1998018754A1 (fr) 1996-10-28 1998-05-07 Versicor, Inc. Procedes pour synthese de composes d'hydroxylamine et derives en phase solide et banques combinatoires correspondantes
CN1243507A (zh) * 1997-01-17 2000-02-02 法玛西雅厄普约翰美国公司 用作mmp抑制剂的双磺酰胺异羟肟酸类化合物
US6376506B1 (en) 1997-01-23 2002-04-23 Syntex (U.S.A.) Llc Sulfamide-metalloprotease inhibitors
ZA98376B (en) * 1997-01-23 1998-07-23 Hoffmann La Roche Sulfamide-metalloprotease inhibitors
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6197791B1 (en) 1997-02-27 2001-03-06 American Cyanamid Company N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
DK0983267T3 (da) * 1997-03-04 2005-04-18 Pharmacia Corp Sulfinamidhydroxamsyreforbindelser med en amidoaromatisk ring
GB9706255D0 (en) 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
NZ338082A (en) * 1997-04-01 2000-06-23 Agouron Pharma Metalloproteinase and Tumor Necrosis Factor-alpha convertase inhibitors, pharmaceutical compositions and their use in treating disease mediated by metalloproteinase activity.
US5756545A (en) * 1997-04-21 1998-05-26 Warner-Lambert Company Biphenysulfonamide matrix metal alloproteinase inhibitors
DE59802394D1 (de) * 1997-05-09 2002-01-24 Hoechst Ag Substituierte Diaminocarbonsäuren
DE19719621A1 (de) 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren
WO1998050348A1 (fr) * 1997-05-09 1998-11-12 Agouron Pharmaceuticals, Inc. Inhibiteurs de metalloproteases, compositions pharmaceutiques les contenant et leurs utilisations pharmaceutiques
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
US6300514B1 (en) 1997-06-25 2001-10-09 Ono Pharmaceutical Co., Ltd. Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient
PL338235A1 (en) 1997-07-22 2000-10-09 Shionogi & Co Preparation for treating or preventing glomerulopathic states
JP2001513484A (ja) 1997-07-31 2001-09-04 ザ プロクター アンド ギャンブル カンパニー 非環式メタロプロテアーゼ阻害剤
DE69805473T2 (de) * 1997-08-08 2003-01-16 Pfizer Products Inc., Groton Arylsulfonylaminohydroxamsäurederivate
US6130220A (en) * 1997-10-16 2000-10-10 Syntex (Usa) Inc. Sulfamide-metalloprotease inhibitors
GB9801690D0 (en) * 1998-01-27 1998-03-25 Pfizer Ltd Therapeutic agents
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
JP4750272B2 (ja) 1998-02-04 2011-08-17 ノバルティス アーゲー マトリックス分解メタロプロテイナーゼを阻害するスルホニルアミノ誘導体
EP1054858A1 (fr) * 1998-02-19 2000-11-29 American Cyanamid Company Alkyle, aryle ou heteroarylamides n-hydroxy-2-(alkyl, aryl ou heteroaryl sulfanyl, sulfinyl ou sulfonyl)-3-substitues en tant qu'inhibiteurs de la metalloproteinase matricielle
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
GB9810464D0 (en) 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
AU754050B2 (en) 1998-07-16 2002-10-31 Sanofi-Aventis Deutschland Gmbh Phosphinous and phosphonic acid derivatives used as medicaments
US6107337A (en) * 1998-08-06 2000-08-22 Pfizer Inc. Arylsulfonylamino hydroxamic acid derivatives
DE19851184A1 (de) 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6946473B2 (en) 1999-01-27 2005-09-20 Wyeth Holdings Corporation Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
US6313123B1 (en) 1999-01-27 2001-11-06 American Cyanamid Company Acetylenic sulfonamide thiol tace inhibitors
US6358980B1 (en) 1999-01-27 2002-03-19 American Cyanamid Company Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
US6753337B2 (en) 1999-01-27 2004-06-22 Wyeth Holdings Corporation Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
US6326516B1 (en) 1999-01-27 2001-12-04 American Cyanamid Company Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
US6340691B1 (en) 1999-01-27 2002-01-22 American Cyanamid Company Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
US6225311B1 (en) 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6762178B2 (en) 1999-01-27 2004-07-13 Wyeth Holdings Corporation Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
US6200996B1 (en) 1999-01-27 2001-03-13 American Cyanamid Company Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
US6277885B1 (en) 1999-01-27 2001-08-21 American Cyanamid Company Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
US6506936B1 (en) * 1999-02-25 2003-01-14 Fibrogen, Inc. N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
RU2001126719A (ru) 1999-03-03 2004-02-20 Дзе Проктер Энд Гэмбл Компани (US) Дигетерозамещенные ингибиторы металлопротеазы
NZ513831A (en) 1999-03-03 2001-09-28 Procter & Gamble Alkenyl- and alkynyl-containing metalloprotease inhibitors
ATE245152T1 (de) 1999-03-31 2003-08-15 Pfizer Prod Inc Dioxocyclopentylhydroxamsäure
HUP0202682A3 (en) 1999-09-10 2003-03-28 Merck & Co Inc Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
US6696456B1 (en) * 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
ES2342344T3 (es) 1999-11-26 2010-07-05 SHIONOGI & CO., LTD. Antagonistas de npy-y5.
US6797820B2 (en) * 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
US6465508B1 (en) 2000-02-25 2002-10-15 Wyeth Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors
AR033356A1 (es) * 2000-03-21 2003-12-17 Procter & Gamble Compuesto que contiene una cadena lateral heterociclica, composicion farmaceutica que lo comprende y uso de dicho compuesto para la fabricacion de un medicamento
WO2001070693A2 (fr) * 2000-03-21 2001-09-27 The Procter & Gamble Company Inhibiteurs de metalloproteases d'acide difluorobutyrique
EP1265864A1 (fr) 2000-03-21 2002-12-18 The Procter & Gamble Company Inhibiteurs de metalloproteases n-substitues renfermant une chaine laterale heterocyclique
AU2001249269A1 (en) * 2000-03-21 2001-10-03 The Procter & Gamble Company Carbocyclic side chain containing metalloprotease inhibitors
US6495358B1 (en) 2000-04-19 2002-12-17 Wichita State University Sulfamide and bis-sulfamide amino acid derivatives as inhibitors of proteolytic enzymes
WO2001092244A1 (fr) 2000-05-30 2001-12-06 Wayne State University Inhibiteurs de metalloproteinases matricielles (mmp)
US20040235896A1 (en) * 2001-03-14 2004-11-25 Fujimoto Roger Aki Certain azacycloalkyl substituted acetic acid derivatives
MXPA03010328A (es) 2001-05-11 2004-02-17 Guilford Pharm Inc Acidos hidroxinamicos y acil hidroxaminasas como inhibidores de naaladasa.
ATE316088T1 (de) 2001-06-22 2006-02-15 Merck & Co Inc Tyrosin-kinase inhibitoren
JP2005507937A (ja) 2001-11-01 2005-03-24 ワイス・ホールディングズ・コーポレイション マトリックスメタロプロテイナーゼおよびｔａｃｅ阻害剤としてのアレンアリールスルホンアミドヒドロキサム酸
WO2003104224A1 (fr) 2002-06-10 2003-12-18 Pfizer Inc. Metabolites de prinomastat et synthese de ceux-ci
US6872724B2 (en) 2002-07-24 2005-03-29 Merck & Co., Inc. Polymorphs with tyrosine kinase activity
WO2005021489A2 (fr) 2002-12-23 2005-03-10 Wyeth Holdings Corporation Tace d'acide hydroxamique sulfonate aryle acetylene et inhibiteurs de metalloproteinase matricielle
CA2509060A1 (fr) * 2002-12-27 2004-07-22 Angiotech International Ag Compositions et procedes d'utilisation de collajolie
EP2181704B1 (fr) 2002-12-30 2015-05-06 Angiotech International Ag Liberation de médicaments a partir d'une composition polymère à gélification rapide
US7576222B2 (en) * 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
US7928127B2 (en) 2005-05-19 2011-04-19 Notre Dame University Inhibitors of matrix metallaproteinases
CN102143942A (zh) * 2008-07-14 2011-08-03 诺瓦提斯公司 选择性的基于异羟肟酸的mmp-12 和mmp-13 抑制剂
WO2011109767A2 (fr) 2010-03-04 2011-09-09 University Of Notre Dame Du Lac Inhibiteurs de la gélatinase et promédicaments
MX2013003362A (es) 2010-09-24 2013-06-05 Ranbaxy Lab Ltd Inhibidores de metaloproteinasa de matriz.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077998A (en) * 1975-10-28 1978-03-07 Morton-Norwich Products, Inc. Phthaloyl amino acid hydroxamic acids
US4885027A (en) * 1985-04-05 1989-12-05 Chevron Research Company Herbicidal arylmethylenesulfonamido-acetamide and thioacetamide derivatives
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
WO1989005787A2 (fr) * 1987-12-18 1989-06-29 Schering Corporation Procedes et composes utiles pour dissoudre de la phenylpropylamine-3 de methyle-1
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
EP0489577B1 (fr) * 1990-12-03 1995-03-22 Celltech Limited Dérivés peptidyliques
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
JPH10501806A (ja) * 1994-06-22 1998-02-17 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
US5817822A (en) * 1994-06-24 1998-10-06 Novartis Corporation Certain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acids
IL126832A0 (en) * 1996-05-17 1999-08-17 Warner Lambert Co Biphenylsulfonamide matrix metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
WO1995035275B1 (fr) Inhibiteurs de metalloproteinases
WO1995035276B1 (fr) Inhibiteurs de metalloproteinases
NZ334186A (en) Neurotrophic heterocyclic esters and amides with an affinity to FKBP-type immunophilins
ATE252572T1 (de) 5-ht1f agonisten
HU9500245D0 (en) Injection and injection kit containing omeprazole and its analogs
IL194483A0 (en) Methods for making proteins containing free cysteine residues
NO965515L (no) Metalloproteinaseinhibitorer
GB0121580D0 (en) Novel compounds
FI895921A0 (fi) Enzymhaemmande aminosyraderivat, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
EP0159863A3 (fr) Amélioration concernant des antibiotiques glycopeptidiques
ATE512202T1 (de) Verfahren zur stabilisierung eines oxidationsfarbbildners
KR850006936A (ko) 티오페닐우레아의 제조방법
NZ337798A (en) Pharmaceutical compositions containing lamivudine
CA2390296A1 (fr) Procede servant a preparer n-(4-hydroxyphenyl)-n'-(4'-aminophenyl)-piperazine
EA199900834A1 (ru) Антивирусные средства
AU683790B2 (en) Nitric esters from derivatives of 2-(2-6-dihalophenylamino) phenylacetoxyacetic acid and their preparation process
ES2154659T3 (es) Soluciones acuosas de isotiazolin-3-onas estables al almacenamiento.
AU740079C (en) Antirheumatic agents
BR9612078A (pt) Solução estabilizada de hidroxilamina uso de pelo menos um composto e processo de estabilizar soluções de hidroxilamina
DE69936527D1 (de) Verwendung von modifiziertem lysozyme c in der herstellung von pharmazeutika zur krankheitsbehandlung
AU3577295A (en) Reagent for the determination of free radicals
BR9915175A (pt) Composições alvejantes
KR840006622A (ko) 1-아로일-5-옥소-2-피롤리딘 프로파논산 및 그의 에스테르의 제조방법
EP0687257A1 (fr) 4-amino-2-(hetero)aryl-butanamides utiles comme antagonistes de la 5-ht1a
CA2271607A1 (fr) Procede pour stabiliser la cyanohydrine
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载